Anti-MAP3K14 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22506; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-MAP3K14 Polyclonal Antibody
The Anti-MAP3K14 Polyclonal Antibody is a highly specific and sensitive tool for the detection of MAP3K14 protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a region within the C-terminal domain of human MAP3K14.
MAP3K14, also known as Mitogen-activated protein kinase kinase kinase 14, is a key regulator of the MAPK signaling pathway. This pathway plays a crucial role in various cellular processes such as cell growth, differentiation, and survival. MAP3K14 is involved in the activation of the JNK and p38 MAPKs, which are important mediators of stress and inflammatory responses.
The Anti-MAP3K14 Polyclonal Antibody is widely used in research studies to investigate the role of MAP3K14 in different biological processes. It is particularly useful in studies related to cancer, as MAP3K14 has been found to be overexpressed in various types of cancer and is associated with tumor growth and progression.
This antibody is suitable for use in various applications, including Western blotting, immunoprecipitation, and immunofluorescence. It has been validated for use in human, mouse, and rat samples, making it a versatile tool for researchers working with different model systems.
In addition to its use in basic research, the Anti-MAP3K14 Polyclonal Antibody has potential applications in drug discovery and development. As MAP3K14 is a potential target for cancer therapy, this antibody can aid in the identification and validation of novel drug candidates.
In summary, the Anti-MAP3K14 Polyclonal Antibody is a reliable and specific tool for the detection of MAP3K14 protein. Its high sensitivity and versatility make it a valuable asset for researchers studying the role of MAP3K14 in various biological processes and for those involved in drug discovery. Trust in the quality and performance of this antibody to advance your research goals. Order now to take the first step towards groundbreaking discoveries.
ProteoGenix catalogue number ARO-A22506. For research use only.
Target: Mitogen-activated protein kinase kinase kinase 14, EC:2.7.11.25, NF-kappa-beta-inducing kinase, HsNIK, Serine/threonine-protein kinase NIK, MAP3K14, NIK; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Mitogen-activated protein kinase kinase kinase 14, EC |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
